IVF Hartmann Holding AG (SWX:VBSN)
Switzerland · Delayed Price · Currency is CHF 137.50
+2.50 (1.85%)
Apr 2, 2026, 5:30 PM CET
IVF Hartmann Holding AG Revenue
In the year 2025, IVF Hartmann Holding AG had annual revenue of 161.85M CHF with 1.77% growth. IVF Hartmann Holding AG had revenue of 84.69M in the half year ending December 31, 2025, with 10.35% growth.
Revenue
161.85M
Revenue Growth
+1.77%
P/S Ratio
2.02
Revenue / Employee
580.12K
Employees
279
Market Cap
327.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 161.85M | 2.82M | 1.77% |
| Dec 31, 2024 | 159.03M | 10.72M | 7.23% |
| Dec 31, 2023 | 148.31M | -2.84M | -1.88% |
| Dec 31, 2022 | 151.15M | 6.35M | 4.38% |
| Dec 31, 2021 | 144.80M | -29.16M | -16.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| DocMorris AG | 1.12B |
| Ascom Holding AG | 292.10M |
| COLTENE Holding AG | 240.05M |
| Basilea Pharmaceutica AG | 232.38M |